Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in
SciELO
Similars in Google
Share
Medicas UIS
Print version ISSN 0121-0319On-line version ISSN 1794-5240
Abstract
FIGUEROA-BUITRAGO, Lorena; DIAZ-GIRALDO, Jorge A and SALDARRIAGA-GIL, Wilmar. Familial hypercholesterolemia due to an heterozygous LDLR promoter mutation: a case report. Medicas UIS [online]. 2024, vol.37, n.3, pp.71-79. Epub Dec 10, 2024. ISSN 0121-0319. https://doi.org/10.18273/revmed.v37n3-2024007.
Familial hypercholesterolemia is a disease caused by mutations in genes related to lipid metabolism, characterized by elevated low-density cholesterol, personal and family history of premature atherosclerotic cardiovascular disease. We present two cases with heterozygous mutation in the promoter of the low-density lipoprotein receptor gene C-135OG. The index case had low-density lipoprotein levels above 300 mg/dL at 10 years old, suffered a major cardiovascular event at the age of 40, and a stroke at 48. At the age of 52, a clinical geneticist built a genogram that suggested an autosomal dominant inheritance pattern of familial hypercholesterolemia and performed a molecular panel for the patient and her daughter at 26 years old. Both cases presented therapeutic failure with lovastatin monotherapy. A significant reduction in cholesterol levels was achieved with dual therapy, in the case 1 with alirocumab+rosuvastatin and case 2 with atorvastatin+ezetimibe.
Keywords : Familial Hypercholesterolemia; Hyperlipoproteinemia Type II; Receptors LDL; Cholesterol; LDL.












